Lyell Immunopharma (LYEL)
(Delayed Data from NSDQ)
$10.98 USD
-0.34 (-3.00%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $10.85 -0.13 (-1.18%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LYEL 10.98 -0.34(-3.00%)
Will LYEL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LYEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LYEL
Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why
After Plunging -37.9% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)
LYEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)
Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround
Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know
Other News for LYEL
12 Health Care Stocks Moving In Thursday's After-Market Session
Lyell Immunopharma (LYEL) Secures $100M Private Placement to Fund Clinical Milestones | LYEL ...
Lyell Immunopharma announces up to $100 million equity private placement
Lyell Immunopharma Announces up to $100 Million Equity Private Placement | LYEL Stock News
Lyell Immunopharma announces up to $100M equity private placement